Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles (2017 - 2026)
Rigel Pharmaceuticals' quarterly Amortizatization of Intangibles came in at $170000.0 in Q1 2026, down 10.53% year-on-year from $190000.0 in Q1 2025, and down 30.04% quarter-over-quarter from $243000.0 in Q4 2025.
Rigel Pharmaceuticals has reported Amortizatization of Intangibles for 10 years, with the latest figure at $170000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 10.53% year-over-year to $170000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 62.82% YoY), and the FY2025 full-year result was $1.2 million, up 62.2% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $170000.0, down from $243000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $467000.0 in Q3 2025, with the low at -$79000.0 in Q2 2022.
- Average Amortizatization of Intangibles over 5 years is $151235.3, with a median of $170000.0 recorded in 2026.
- Year-over-year, Amortizatization of Intangibles plunged 690.0% in 2022 and soared 1266.67% in 2023.
- Tracing RIGL's Amortizatization of Intangibles over 5 years: stood at $179000.0 in 2022, then jumped by 45.25% to $260000.0 in 2023, then advanced by 6.15% to $276000.0 in 2024, then fell by 11.96% to $243000.0 in 2025, then tumbled by 30.04% to $170000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $170000.0 (Q1 2026), $243000.0 (Q4 2025), and $467000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | 170,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,000.00 |
| Mar 31, 2026 | 170,000.00 |
| Dec 31, 2025 | 243,000.00 |
| Dec 31, 2025 | 243,000.00 |
| Sep 30, 2025 | 467,000.00 |
| Sep 30, 2025 | 467,000.00 |
| Jun 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 250,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 276,000.00 |
| Dec 31, 2024 | 276,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Sep 30, 2024 | 69,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 205,000.00 |
| Mar 31, 2024 | 205,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Dec 31, 2023 | 260,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 179,000.00 |
| Dec 31, 2022 | 179,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -79,000.00 |
| Jun 30, 2022 | -79,000.00 |
| Mar 31, 2022 | -28,000.00 |
| Mar 31, 2022 | -28,000.00 |
| Dec 31, 2021 | -116,000.00 |
| Dec 31, 2021 | -116,000.00 |
| Sep 30, 2021 | -76,000.00 |
| Sep 30, 2021 | -76,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Mar 31, 2021 | -85,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Dec 31, 2020 | -49,000.00 |
| Sep 30, 2020 | -36,000.00 |
| Sep 30, 2020 | -36,000.00 |
| Jun 30, 2020 | 69,000.00 |
| Jun 30, 2020 | 69,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Dec 31, 2019 | 156,000.00 |
| Dec 31, 2019 | 156,000.00 |
| Sep 30, 2019 | 304,000.00 |
| Sep 30, 2019 | 304,000.00 |
| Jun 30, 2019 | 331,000.00 |
| Jun 30, 2019 | 331,000.00 |
| Mar 31, 2019 | 282,000.00 |
| Mar 31, 2019 | 282,000.00 |
| Dec 31, 2018 | 225,000.00 |
| Dec 31, 2018 | 225,000.00 |
| Sep 30, 2018 | 224,000.00 |
| Sep 30, 2018 | 224,000.00 |
| Jun 30, 2018 | 183,000.00 |
| Jun 30, 2018 | 183,000.00 |
| Mar 31, 2018 | 134,000.00 |
| Mar 31, 2018 | 134,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Dec 31, 2017 | 152,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 74,000.00 |
| Jun 30, 2017 | 74,000.00 |
| Mar 31, 2017 | 33,000.00 |
| Mar 31, 2017 | 33,000.00 |